CT1390B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT1390B, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia [Phase 1]